Evidence map›Paper›PMID 29789676›Full record

ReviewThe pharmacogenomics journal2018

The angiotensin-I-converting enzyme insertion/deletion in polymorphic element codes for an AluYa5 RNA that downregulates gene expression.

Fernando F P Mafra, Pedro P Gattai, Michel M Macedo, Marcelo A Mori, Ronaldo C Araujo

Abstract readReview
PubMed Publisher
In one paragraph

Review in The pharmacogenomics journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. The association ofEXCLI journal · 2022
    Review
  6. Review
  7. Genes · 2021
    Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Fernando F P MafraDept. of Biophysics, Federal University of São Paulo, São Paulo, Brazil.
Pedro P GattaiDept. of Biophysics, Federal University of São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-6417-8815
Michel M MacedoDept. of Biophysics, Federal University of São Paulo, São Paulo, Brazil.
Marcelo A MoriDept. of Biophysics, Federal University of São Paulo, São Paulo, Brazil.
Ronaldo C AraujoDept. of Biophysics, Federal University of São Paulo, São Paulo, Brazil. araujo.ronaldo@unifesp.br.ORCID http://orcid.org/0000-0003-0095-4608
Universidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiotensin-I-converting enzyme (ACE) is involved in the synthesis and degradation of important bioactive peptides. The ACE gene has a 287-bp insertion/deletion polymorphism that controls ACE expression through a mechanism that remains elusive. In this study, we found that the 287-bp polymorphic element of the ACE gene, a member of the AluYa5 sub-family of Alu elements, codes for an RNA molecule that controls the levels of ACE mRNA. Transient transfection of a plasmid containing a CMV promoter upstream of the ACE polymorphic element resulted in significant expression of an AluYa5 RNA and reduced ACE mRNA expression as well as ACE enzymatic activity in AD 293 cells. The AluYa5 element also independently reduced the expression of other genes, regardless of whether these genes harbored Alu elements within their genomic context. Interestingly, the CMV promoter was not required for the expression of the AluYa5 element in AD 293 cells. The 287-bp sequence was sufficient to produce AluYa5 RNA and led to a significant reduction in ACE gene expression. Moreover, the removal of an 11-bp fragment of the 3' end of the ACE polymorphic sequence, which is specific to this particular AluYa5 element, did not prevent this element from being expressed but did affect its ability to target ACE expression. Thus, the expression of the AluYa5 polymorphic element within the ACE gene could explain why patients carrying the ACE insertion polymorphism have reduced risk of developing several chronic diseases.

Indexed as

PharmacogeneticsAlu ElementsGene Expression RegulationHumansINDEL MutationPeptidyl-Dipeptidase APolymorphism, GeneticPromoter Regions, GeneticRisk FactorsRNARNA, MessengerPeptidyl-Dipeptidase ARNARNA, Messenger

Identifiers

PMID29789676
OpenAlexW2804999160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.